The AAO-HNS/F OTO Forum provides an intimate forum for leadership discussions and practice management tools, highlighting the current and future needs of private practice physicians caring for otolaryngologic patients. The program will thematically focus on all things private practice otolaryngology with the guideposts of networking, benchmarking, innovation, and healthcare trends. This program includes didactic and interactive sessions led by peers and subject matter experts in the specialty.
By attending the AAO-HNS/F OTO Forum attendees will be able to:
- Analyze key financial benchmarks and data analytics in private practice to assess operational efficiency and identify opportunities for revenue growth and cost reduction.
- Evaluate emerging trends in artificial intelligence, technology, and in-office procedures to determine their applicability and potential impact on patient outcomes and practice workflow.
- Apply best practices in employee retention, physician-payer relations, and advocacy efforts to enhance practice culture, optimize reimbursement strategies, and improve patient access to care.
- Create strategic marketing and reputation management plans tailored to different budget levels to effectively position and grow a private ENT practice.
- Demonstrate proficiency in coding, billing, and regulatory compliance by integrating updated payment considerations and value-based care models into practice operations.
Target Audience
The OTO Forum is designed for otolaryngology-head and neck surgery residents, young physicians, and physician members.
Accreditation
This meeting has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. AAO-HNSF is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Claiming CME/MOC Credit
OTO Logic
AAO-HNSF designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Participants should only claim credit commensurate with the extent of their participation. The OTOLogic team will be emailing you a link to complete your evaluation to claim your CME/MOC credit.
Deadline to claim credit is May 27, 2025.
Need assistance? Visit the CME webpage or contact us at [email protected]
The following sessions are approved for CME and will also count for MOC.
Friday, April 25
|
0.75 |
|
0.75 |
|
0.75 |
|
1.0 |
|
1.0 |
|
1.0 |
|
1.0 |
Saturday, April 26
|
1.0 |
|
0.75 |
|
0.75 |
|
1.0 |
|
0.75 |
|
0.75 |
|
1.0 |
This session is not eligible for CME/MOC credit:
- Hearing Aid Industry Leaders Panel: Maximizing Best Hearing Healthcare
Presenter Disclosure of Relevant Financial Relationships
The AAO-HNSF is committed to creating high-quality education that is independent of industry influence. All persons who have been in control of this educational content for this accredited CE activity has been asked to disclose all financial relationships with any ineligible companies they have had over the past 24 months.
The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum threshold; all financial relationships, regardless of amount, with ineligible companies.
The ACCME also requires that AAO-HNSF manage any reported conflict and eliminate the potential for bias during the educational activity. All of the relevant financial relationships listed for these individuals have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
| Disclosures | Nothing to Disclose |
Disclosure |
|||
| Company | Role | Received | |||
| Planning Committee | |||||
| Rahul K. Shah, MD, MBA | Csurgeries
ScribeBrain AI LLC SpringerNature Zoc AI Products DHVP Fund I, Digital Health Venture |
Stock or Stock Options
Stock Or Stock Options Royalty Stock Or Stock Options Stock Or Stock Options
|
|||
| Annette M. Pham, MD | X | ||||
| Taniza Holmes-Craggette | X | ||||
| Meghan Callahan, CMP | X | ||||
| Beth Burchill, CMP | X | ||||
| Elise Emmons, MA | X | ||||
| Faculty | |||||
| Jason L. Acevedo, MD, MBA, FAAOA | X | ||||
| Douglas D. Backous, MD | Grace Medical
Healthy Hearing Ears Initiative |
Royalty
Honoraria |
|||
| Cristina Baldassari, MD | Nyxoah | Consultant | Consulting Fee | ||
| Brad Bichey, MD, MPH | Nemedic, Inc. | Intellectual Property Rights | |||
| Eugene G. Brown, III, MD, RPh | Neurent | Consultant | Consulting Fee | ||
| G. Lee Bryant, Jr., MD | X | ||||
| Neal W. Burkhalter, MD | X | ||||
| Marc G. Dubin | Stryker
Neurent Medtronic Integra Synopsis |
Consultant | Consulting Fee
Consulting Fee Consulting Fee Consulting Fee Stock or Stock Options |
||
| Julie Farley | Auris Practice Solutions, LLC | ||||
| D. Scott Fortune, MD | X | ||||
| Drew Franklin | X | ||||
| Daniel R. Gold, MD | X | ||||
| David A. Godin, MD | |||||
| Jennifer L. Goodrich, MD | X | ||||
| Eli R. Groppo, MD | X | ||||
| Jedidiah J. Grisel, MD | Amplify Hearing USA | Stock or Stock Options | |||
| Willard C. Harrill, MD | BridgepointMD | Stock or Stock Options | |||
| Andrew Johnson, MD | X | ||||
| Srinivas R. Kaza, MD | X | ||||
| Carlos Lopez | X | ||||
| Michelle F. Liu, MD, MPH | X | ||||
| Lance A. Manning, MD | X | ||||
| Nora W. Perkins, MD | Aerin Medical
Stryker |
Consultant | Consulting Fee | ||
| Eileen M. Raynor, MD | Inspire
Ambu NCMS |
Consultant President |
Research Funding
Consulting Fee |
||
| Douglas D. Reh, MD | NeurEnt
Sound Health Optinose |
Consultant
|
Consulting Fee
Honoraria |
||
| Geoff Rosenthal, MD | |||||
| Matthew Scarlett, MD | X | ||||
| Troy Simonson | X | ||||
| Elise Swinehart | X | ||||
| Holly Thompson | |||||
| Andrew J. Tompkins, MD, MBA | X | ||||
| Camille White | X | ||||
| Melanie Wilson Seybt, MD | X | ||||
| Jeffrey S. Weingarten, MD | CQ Partners
Medical Hearing Consultants, LLC |
Consultant
|
Consulting Fee
|
||
| Kevin Watson | X | ||||
| David M. Yen, MD | 3-D Matrix
Aerin Medical Astra Zeneca AventaMed Capital Blue Cross Cyrano Therapeutics DiagNose Medical GSK Lyra Therapeutics Medtronic Neubio North America Neurent Medical OptiNose Oyster Point Pharmaceutical Pocket Naloxone Regeneron Sanofi Spirair Stryker Eli Lilly Tympanogen Evidera |
Consultant
Consultant
Consultant
Consultant
Consultant
|
Consulting Fee
Research Funding Research Funding Research Funding Research Funding Stock or Stock Options Stock or Stock Options Research Funding Research Funding Consulting Fee Consulting Fee
Consulting Fee Research Funding
Consulting Fee Research Funding Honoraria Honoraria Research Funding Consulting Fee Research Funding Research Funding Research Funding |
||
| Justin Wyrick | X | ||||
| Dianne Williams | X | ||||
Clinical Medicine Recommendations/Scientific Research Reporting
The AAO-HNS informs all presenters and expects that:
- All recommendations involving clinical medicine in a professional education activity must be based on evidence that is accepted within the profession of medicine as adequate justification for the indications and contradictions in the care of patients; and
- All scientific research referred to, reported, or used in professional education in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Free Exchange of Medical Education Statement
AAO-HNSF is committed to the free exchange of medical education. Inclusion of any presentation or exhibit in this activity, including presentations or exhibits on drugs or medical devices, or the uses of drugs or medical devices that have not been approved by the FDA, does not imply an endorsement by the AAO-HNSF of the uses, products, or techniques presented.
The information contained in this activity represents the views of those who created it and does not necessarily represent the official view or recommendations of AAO-HNSF.
Deadline to claim credit is May 27, 2025.
Need assistance? Visit the CME webpage or contact us at [email protected]
